Search Results - "KEHLER, Jan"
-
1
PDE10A inhibitors: novel therapeutic drugs for schizophrenia
Published in Current pharmaceutical design (2011)“…Disturbances of the basal ganglia processes is heavily involved in schizophrenia. Phosphodiesterase 10A (PDE10A) is a basal ganglia specific hydrolase, which…”
Get more information
Journal Article -
2
In Vitro and In Vivo Evidence for Active Brain Uptake of the GHB Analog HOCPCA by the Monocarboxylate Transporter Subtype 1
Published in The Journal of pharmacology and experimental therapeutics (01-08-2015)“…γ-Hydroxybutyric acid (GHB) is a recreational drug, a clinically prescribed drug in narcolepsy and alcohol dependence, and an endogenous substance that binds…”
Get more information
Journal Article -
3
From pan-reactive KV7 channel opener to subtype selective opener/inhibitor by addition of a methyl group
Published in PloS one (23-06-2014)“…The voltage-gated potassium channels of the KV7 family (KV7.1-5) play important roles in controlling neuronal excitability and are therefore attractive targets…”
Get full text
Journal Article -
4
Discovery of the First Selective Inhibitor of Excitatory Amino Acid Transporter Subtype 1
Published in Journal of medicinal chemistry (26-02-2009)“…The discovery of the first class of subtype-selective inhibitors of the human excitatory amino acid transporter subtype 1 (EAAT1) and its rat orthologue GLAST…”
Get full text
Journal Article -
5
Discovery and development of 11C-Lu AE92686 as a radioligand for PET imaging of phosphodiesterase10A in the brain
Published in The Journal of nuclear medicine (1978) (01-09-2014)“…Phosphodiesterase 10A (PDE10A) plays a key role in the regulation of brain striatal signaling, and several pharmaceutical companies currently investigate…”
Get full text
Journal Article -
6
Synthesis of enantiomerically pure milnacipran analogs and inhibition of dopamine, serotonin, and norepinephrine transporters
Published in Bioorganic & medicinal chemistry letters (15-05-2007)“…Two enantiomeric series of milnacipran analogs have been synthesized and their effects on 5-HT, NE, and DA uptake inhibition have been measured. A series of…”
Get full text
Journal Article -
7
Phosphodiesterase 10A inhibitors: a 2009 - 2012 patent update
Published in Expert opinion on therapeutic patents (01-01-2013)“…Inhibitors of the phosphodiesterase enzyme PDE10A have been the target for extensive investigations and huge drug discovery research efforts during the recent…”
Get more information
Journal Article -
8
Patented PDE10A inhibitors: novel compounds since 2007
Published in Expert opinion on therapeutic patents (01-12-2009)“…PDE10A inhibition has generated much excitement as a potential novel mechanism for the treatment of the positive symptoms of schizophrenia. PDE10A is only '10…”
Get more information
Journal Article -
9
Phosphodiesterase type 1 inhibition alters medial prefrontal cortical activity during goal-driven behaviour and partially reverses neurophysiological deficits in the rat phencyclidine model of schizophrenia
Published in Neuropharmacology (15-03-2021)“…Positive modulation of cAMP signalling by phosphodiesterase (PDE) inhibitors has recently been explored as a potential target for the reversal of cognitive and…”
Get full text
Journal Article -
10
Phosphodiesterase 1 Bridges Glutamate Inputs with NO- and Dopamine-Induced Cyclic Nucleotide Signals in the Striatum
Published in Cerebral cortex (New York, N.Y. 1991) (17-12-2019)“…Abstract The calcium-regulated phosphodiesterase 1 (PDE1) family is highly expressed in the brain, but its functional role in neurones is poorly understood…”
Get full text
Journal Article -
11
Synthesis and SAR study of novel tricyclic pyrazoles as potent phosphodiesterase 10A inhibitors
Published in European journal of medicinal chemistry (12-09-2014)“…Novel pyrazolo[5,1-f][1,6]naphthyridines, pyrazolo[5,1-a][2,6]naphthyridines, pyrazolo[5,1-a][2,7]naphthyridines and pyrazolo[5,1-a]isoquinolines…”
Get full text
Journal Article -
12
Ortho lithiation-in situ borylation of substituted morpholine benzamides
Published in Tetrahedron (23-03-2017)“…Morpholine amides are cheap and safe alternative to Weinreb amides as acylating agents of organometallic species. Herein, the in-situ lithiation/borylation of…”
Get full text
Journal Article -
13
Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats
Published in British journal of pharmacology (01-08-2017)“…Background and Purpose The PDE enzymes (PDE1–11) hydrolyse and thus inactivate cyclic nucleotides and are important in the regulation of the cardiovascular…”
Get full text
Journal Article -
14
PDE1A inhibition elicits cGMP‐dependent relaxation of rat mesenteric arteries
Published in British journal of pharmacology (01-11-2017)“…Background and Purpose PDE1, a subfamily of cyclic nucleotide PDEs consisting of three isoforms, PDE1A, PDE1B and PDE1C, has been implicated in the regulation…”
Get full text
Journal Article -
15
Discovery of 2‑(Imidazo[1,2‑b]pyridazin-2-yl)acetic Acid as a New Class of Ligands Selective for the γ‑Hydroxybutyric Acid (GHB) High-Affinity Binding Sites
Published in Journal of medicinal chemistry (14-03-2019)“…Gabazine, a γ-aminobutyric acid type A (GABAA) receptor antagonist, has previously been reported to inhibit the binding of [3H]NCS-382, a representative…”
Get full text
Journal Article -
16
Potentiation of NGF-induced neurite outgrowth in PC12 cells by papaverine: Role played by PLC-γ, IP3 receptors
Published in Brain research (04-03-2011)“…Abstract Papaverine, an inhibitor of phosphodiesterase (PDE) 10A, is gaining attention for its potential in the treatment of neuropsychiatric diseases such as…”
Get full text
Journal Article -
17
Debenzylative Cycloetherification as a Synthetic Tool in the Diastereoselective Synthesis of 3,6-Disubstituted Hexahydro-2 H -furo[3,2- b ]pyrroles, PDE1 Enzyme Inhibitors with an Antiproliferative Effect on Melanoma Cells
Published in Journal of organic chemistry (01-05-2020)“…Two series of novel chiral hexahydro-2 -furo[3,2- ]pyrroles, 4-(7,8-dimethoxyquinazolin-4-yl) series A and 4-(6,7- dimethoxyquinazolin-4-yl) series B, were…”
Get full text
Journal Article -
18
Debenzylative Cycloetherification as a Synthetic Tool in the Diastereoselective Synthesis of 3,6-Disubstituted Hexahydro‑2H‑furo[3,2‑b]pyrroles, PDE1 Enzyme Inhibitors with an Antiproliferative Effect on Melanoma Cells
Published in Journal of organic chemistry (01-05-2020)“…Two series of novel chiral hexahydro-2H-furo[3,2-b]pyrroles, 4-(7,8-dimethoxyquinazolin-4-yl) series A and 4-(6,7- dimethoxyquinazolin-4-yl) series B, were…”
Get full text
Journal Article -
19
Molecular Hybridization of Potent and Selective γ‑Hydroxybutyric Acid (GHB) Ligands: Design, Synthesis, Binding Studies, and Molecular Modeling of Novel 3‑Hydroxycyclopent-1-enecarboxylic Acid (HOCPCA) and trans-γ-Hydroxycrotonic Acid (T-HCA) Analogs
Published in Journal of medicinal chemistry (09-11-2017)“…γ-Hydroxybutyric acid (GHB) is a neuroactive substance with specific high-affinity binding sites. To facilitate target identification and ligand optimization,…”
Get full text
Journal Article -
20
Correlating the Metabolic Stability of Psychedelic 5-HT2A Agonists with Anecdotal Reports of Human Oral Bioavailability
Published in Neurochemical research (01-10-2014)“…2,5-Dimethoxyphenethylamines and their N -benzylated derivatives are potent 5-HT 2A agonists with psychedelic effects in humans. The N -benzylated derivatives…”
Get full text
Journal Article